Preparation of trans-fused 3,3a,8,12b-tetrahydro-2H-dibenzo[3,4:6 ,7]cyclohepta[1,2-b]furan derivatives

Details for Australian Patent Application No. 2002342926 (hide)

International Classifications

Event Publications

27 February 2003 Complete Application Filed

Priority application(s): 01204961.5 07.12.01 EP

21 August 2003 Application Open to Public Inspection

Published as AU-B-2002342926

26 February 2009 Application Accepted

Published as AU-B-2002342926

25 June 2009 Standard Patent Sealed

3 November 2011 Assignment Registered

Janssen Pharmaceutica N.V. The patent has been assigned to Elanco Animal Health Ireland Limited

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.